- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
IPCA Laboratories Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting
13-02-2026 | 01:38 pm
13-02-2026 | 01:38 pm
Ipca Labs' board approved Q3 & 9M results. Consolidated Net Profit surged 31% to ₹326.27 Cr with revenue up 7%. Strategic moves include Unichem Ireland acquisition, a new German subsidiary, and Unichem's ₹279 Cr land sale, contributing a ₹17.65 Cr gain.
No comments yet. Be the first to comment!